NOI - Oxford Nanopore PromethION Flow Cells and cD
Contract Opportunity Analysis
The National Institutes of Health, through the Office of Acquisitions, is seeking a non-competitive firm-fixed-price purchase order for Oxford Nanopore PromethION flow cells and cDNA-PCR sequencing kits to support the National Institute on Aging’s Center for Alzheimer’s Disease and Related Dementias long-read RNA sequencing project. The work centers on supplying proprietary reagents needed to operate the existing PromethION 48 sequencing infrastructure and to compare results with previously generated long-read whole-genome sequencing data from ROSMAP brain samples. The requirement is tied to Oxford Nanopore’s proprietary FLO-PRO114M flow cells and SQK-LSK114-XL kit, with a six-month period of performance. Responses are due by June 8, 2026, at 9:00 AM EDT, and offerors must provide detailed price quotations and product information while being registered in SAM.